These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11762182)

  • 21. Aminoguanidine and metformin prevent the reduced rate of HDL-mediated cell cholesterol efflux induced by formation of advanced glycation end products.
    Machado AP; Pinto RS; Moysés ZP; Nakandakare ER; Quintão EC; Passarelli M
    Int J Biochem Cell Biol; 2006 Mar; 38(3):392-403. PubMed ID: 16288898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular pathophysiology of late complications diabetes mellitus--hyperglycemia-induced changes].
    Kanková K
    Vnitr Lek; 2004 Oct; 50(10):756-67. PubMed ID: 15633931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications.
    Saraswat M; Reddy PY; Muthenna P; Reddy GB
    Br J Nutr; 2009 Jun; 101(11):1714-21. PubMed ID: 18986599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term complications in diabetes mellitus: role of irreversible glycosylation products].
    Treskes M; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 1996 Jun; 140(25):1299-303. PubMed ID: 8710007
    [No Abstract]   [Full Text] [Related]  

  • 25. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.
    Rojas A; Morales MA
    Life Sci; 2004 Dec; 76(7):715-30. PubMed ID: 15581904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.
    Kim YS; Kim NH; Lee SW; Lee YM; Jang DS; Kim JS
    Eur J Pharmacol; 2007 Aug; 569(3):171-9. PubMed ID: 17597607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nonenzymatic glycation of proteins and nucleic acids, their importance for the development of diabetic complications, possible molecular basis of aging and autoimmunological processes.
    Krantz S; Lober M; Henschel L
    Exp Clin Endocrinol; 1986 Dec; 88(3):257-69. PubMed ID: 3549330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glyco-oxidation in diabetes and related diseases.
    Lapolla A; Fedele D; Traldi P
    Clin Chim Acta; 2005 Jul; 357(2):236-50. PubMed ID: 15939413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
    Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
    Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of macrophages in complications of type 2 diabetes.
    Tesch GH
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1016-9. PubMed ID: 17714088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tissue self-oxidative glycosylation and chronic complications of diabetes mellitus].
    Li XJ; Liang JZ; Qian RL
    Zhonghua Yi Xue Za Zhi; 1993 Sep; 73(9):565-7. PubMed ID: 8313202
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycation products and the pathogenesis of diabetic complications.
    Brownlee M
    Diabetes Care; 1992 Dec; 15(12):1835-43. PubMed ID: 1464241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-enzymatic acetylation of proteins by aspirin as protection against the secondary complications of diabetes mellitus.
    Hun-Opfer C; Mata-Segreda JF
    Acta Physiol Pharmacol Latinoam; 1986; 36(3):313-6. PubMed ID: 3577806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of non-enzymatic glycosylation of proteins in the pathogenesis of diabetic complications].
    Sampietro T
    Minerva Endocrinol; 1988; 13(4):249-51. PubMed ID: 2976478
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological modulation of the advanced glycosylation reaction.
    Brownlee M
    Prog Clin Biol Res; 1989; 304():235-48. PubMed ID: 2675030
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases.
    Méndez JD; Xie J; Aguilar-Hernández M; Méndez-Valenzuela V
    Mol Cell Biochem; 2010 Nov; 344(1-2):185-93. PubMed ID: 20680411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a basic understanding of diabetic complications.
    Steffes MW; Mauer SM
    N Engl J Med; 1991 Sep; 325(12):883-4. PubMed ID: 1875974
    [No Abstract]   [Full Text] [Related]  

  • 39. Lilly Lecture 1993. Glycation and diabetic complications.
    Brownlee M
    Diabetes; 1994 Jun; 43(6):836-41. PubMed ID: 8194672
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic diabetic complications and tissue glycosylation. Relevant concern for diabetes-prone black population.
    Vlassara H
    Diabetes Care; 1990 Nov; 13(11):1180-5. PubMed ID: 2261839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.